Johnson & Johnson
JNJ
Delayed Nyse - 09/21 10:01:19 pm
142.88USD
+0.63%
Prev.141.9800
Open142.1800
High143.1300
Low141.6900
Volume13 283 427
Financials
Sales 2018 81 257 M
EBIT 2018 24 952 M
R. net 2018 16 036 M
Debt 2018 11 280 M
Rend. 2018 2,50%
P/E ratio 2018 21,10
P/E ratio 2019 18,25
EV / Sales 2018 4,86x
EV / Sales 2019 4,62x
Capitalization 383 B
Company
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices.The Consumer segment includes products used in the baby care,...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-09-23 Presentation
Trading Rating :
Investor Rating :
Latest news
09/22HIGH SCHOOL FOOTBALL : West Rowan-Concord box
AQ
09/22J&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary Endpoint
DJ
09/22JOHNSON & JOHNSON : 'Healthy Babies Are Worth the Wait' program to be held on Wednesday
AQ
09/22JOHNSON & JOHNSON : Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
PU
09/21JOHNSON & JOHNSON : J&J Unit Agrees To Sell Sterilization Unit for $2.7 Billion
DJ
09/21JOHNSON & JOHNSON : to Host Investor Conference Call on Third-Quarter Results
AQ
09/21JOHNSON & JOHNSON : Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
AQ
09/21JOHNSON & JOHNSON : Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance145148147
Spread/Res.-1,7%-3,6%-3,0%
Spread/Supp.4,4%10%18%
Support137130121